Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
December-2019 Volume 44 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2019 Volume 44 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy

  • Authors:
    • Miriam Carbo
    • Valentina Brandi
    • Gianmarco Pascarella
    • David Sasah Staid
    • Gianni Colotti
    • Fabio Polticelli
    • Andrea Ilari
    • Veronica Morea
  • View Affiliations / Copyright

    Affiliations: Department of Biochemical Sciences ‘A. Rossi Fanelli’, Sapienza University, I‑00185 Rome, Italy, Department of Sciences, Roma Tre University, I‑00159 Rome, Italy, Institute of Molecular Biology and Pathology of The National Research Council of Italy, I‑00185 Rome, Italy
    Copyright: © Carbo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2223-2233
    |
    Published online on: October 15, 2019
       https://doi.org/10.3892/ijmm.2019.4373
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Huntington's disease (HD) is a lethal neurodegenerative disorder for which no cure is available yet. It is caused by abnormal expansion of a CAG triplet in the gene encoding the huntingtin protein (Htt), with consequent expansion of a polyglutamine repeat in mutated Htt (mHtt). This makes mHtt highly unstable and aggregation prone. Soluble mHtt is linked to cytotoxicity and neurotoxicity, whereas mHtt aggregates are thought to be neuroprotective. While Htt and mHtt are ubiquitously expressed throughout the brain and peripheral tissues, HD is characterized by selective degradation of the corpus striatum, without notable alterations in peripheral tissues. Screening for mRNAs preferentially expressed in rodent striatum led to the discovery of a GTP binding protein homologous to Ras family members. Due to these features, the newly discovered protein was termed Ras Homolog Enriched in Striatum (RHES). The aetiological role of RHES in HD has been ascribed to its small ubiquitin‑like modifier (SUMO)‑E3 ligase function. RHES sumoylates mHtt with higher efficiency than wild‑type Htt, thereby protecting mHtt from degradation and increasing the amounts of the soluble form. Although RHES is an attractive target for HD treatment, essential information about protein structure and function are still missing. With the aim of investigating RHES 3D structure and function, bioinformatic analyses and molecular modelling have been performed in the present study, based on which, RHES regions predicted to be involved in the interaction with mHtt or the SUMO‑E2 ligase Ubc9 have been identified. These regions have been used to design peptides aimed at inhibiting RHES interactions and, therefore, mHtt sumoylation; in turn, these peptides will be used to develop small molecule inhibitors by both rational design and virtual screening of large compound libraries. Once identified, RHES sumoylation inhibitors may open the road to the development of therapeutic agents against the severe, and currently untreatable, HD.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Testa CM and Jankovic J: Huntington disease: A quarter century of progress since the gene discovery. J Neurol Sci. 396:52–68. 2019. View Article : Google Scholar

2 

Gusella JF and MacDonald ME: Huntington's disease: CAG genetics expands neurobiology. Curr Opin Neurobiol. 5:656–662. 1995. View Article : Google Scholar : PubMed/NCBI

3 

Saudou F, Finkbeiner S, Devys D and Greenberg ME: Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 95:55–66. 1998. View Article : Google Scholar : PubMed/NCBI

4 

Gong B, Lim MC, Wanderer J, Wyttenbach A and Morton AJ: Time-lapse analysis of aggregate formation in an inducible PC12 cell model of Huntington's disease reveals time-dependent aggregate formation that transiently delays cell death. Brain Res Bull. 75:146–157. 2008. View Article : Google Scholar

5 

Lu B and Palacino J: A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J. 27:1820–1829. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Harrison LM and Lahoste GJ: The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes. Exp Cell Res. 319:2310–2315. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Sipione S and Cattaneo E: Modeling Huntington's disease in cells, flies, and mice. Mol Neurobiol. 23:21–52. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Shahani N, Swarnkar S, Giovinazzo V, Morgenweck J, Bohn LM, Scharager-Tapia C, Pascal B, Martinez-Acedo P, Khare K and Subramaniam S: RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ('Rhesactome') in the striatum. Sci Signal. 9:ra1112016. View Article : Google Scholar

9 

Valjent E: Striatal signaling: Two decades of progress. Front Neuroanat. 6:432012. View Article : Google Scholar : PubMed/NCBI

10 

Ross CA and Tabrizi SJ: Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurol. 10:83–98. 2011. View Article : Google Scholar

11 

Falk JD, Vargiu P, Foye PE, Usui H, Perez J, Danielson PE, Lerner DL, Bernal J and Sutcliffe JG: Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res. 57:782–788. 1999. View Article : Google Scholar : PubMed/NCBI

12 

Subramaniam S, Sixt KM, Barrow R and Snyder SH: Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science. 324:1327–1330. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Subramaniam S, Mealer RG, Sixt KM, Barrow RK, Usiello A and Snyder SH: Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. J Biol Chem. 285:20428–20432. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Seredenina T, Gokce O and Luthi-Carter R: Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One. 6:e222312011. View Article : Google Scholar : PubMed/NCBI

15 

Baiamonte BA, Lee FA, Brewer ST, Spano D and LaHoste GJ: Attenuation of Rhes activity significantly delays the appearance of behavioral symptoms in a mouse model of Huntington's disease. PLoS One. 8:e536062013. View Article : Google Scholar : PubMed/NCBI

16 

Mealer RG, Subramaniam S and Snyder SH: Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease. J Neurosci. 33:4206–4210. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Lee JH, Sowada MJ, Boudreau RL, Aerts AM, Thedens DR, Nopoulos P and Davidson BL: Rhes suppression enhances disease phenotypes in Huntington's disease mice. J Huntingtons Dis. 3:65–71. 2014.PubMed/NCBI

18 

Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, et al: Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 36:585–595. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Subramaniam S, Napolitano F, Mealer RG, Kim S, Errico F, Barrow R, Shahani N, Tyagi R, Snyder SH and Usiello A: Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci. 15:191–193. 2012. View Article : Google Scholar

20 

Mealer RG, Murray AJ, Shahani N, Subramaniam S and Snyder SH: Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J Biol Chem. 289:3547–3554. 2014. View Article : Google Scholar :

21 

Naseri NN, Xu H, Bonica J, Vonsattel JP, Cortes EP, Park LC, Arjomand J and Gibson GE: Abnormalities in the tricarboxylic acid cycle in Huntington disease and in a Huntington disease mouse model. J Neuropathol Exp Neurol. 74:527–537. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Golas MM and Sander B: Use of human stem cells in Huntington disease modeling and translational research. Exp Neurol. 278:76–90. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Stricker-Shaver J, Novati A, Yu-Taeger L and Nguyen HP: Genetic rodent models of Huntington disease. Adv Exp Med Biol. 1049:29–57. 2018. View Article : Google Scholar : PubMed/NCBI

24 

UniProt Consortium: Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res. 42(Database Issue): D191–D198. 2014. View Article : Google Scholar :

25 

Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN and Bourne PE: The protein data bank. Nucleic Acids Res. 28:235–242. 2000. View Article : Google Scholar

26 

Altschul S, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ: Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402. 1997. View Article : Google Scholar : PubMed/NCBI

27 

Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al: Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 7:5392011. View Article : Google Scholar : PubMed/NCBI

28 

Guex N and Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis. 18:2714–2723. 1997. View Article : Google Scholar

29 

Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC and Ferrin TE: UCSF Chimera-A visualization system for exploratory research and analysis. J Comput Chem. 25:1605–1612. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Krissinel E and Henrick K: Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr Sect D Biol Crystallogr. 60:2256–2268. 2004. View Article : Google Scholar

31 

Finn RD, Coggill P, Eberhardt RY, Eddy SR, Mistry J, Mitchell AL, Potter SC, Punta M, Qureshi M, Sangrador-Vegas A, et al: The Pfam protein families database: Towards a more sustainable future. Nucleic Acids Res. 44:D279–D285. 2016. View Article : Google Scholar :

32 

Pandurangan AP, Stahlhacke J, Oates ME, Smithers B and Gough J: The SUPERFAMILY 2.0 database: A significant proteome update and a new webserver. Nucleic Acids Res. 47:D490–D494. 2019. View Article : Google Scholar :

33 

Roy A, Kucukural A and Zhang Y: I-TASSER: A unified platform for automated protein structure and function prediction. Nat Protoc. 5:725–738. 2010. View Article : Google Scholar : PubMed/NCBI

34 

Söding J, Biegert A and Lupas AN: The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res. 33(Web Server Issue): W244–W248. 2005. View Article : Google Scholar : PubMed/NCBI

35 

Kelley LA, Mezulis S, Yates CM, Wass MN and Sternberg MJ: The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 10:845–858. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Drozdetskiy A, Cole C, Procter J and Barton GJ: JPred4: A protein secondary structure prediction server. Nucleic Acids Res. 43:W389–W394. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Buchan DW, Minneci F, Nugent TC, Bryson K and Jones DT: Scalable web services for the PSIPRED protein analysis Workbench. Nucleic Acids Res. 41(Web Server Issue): W349–W357. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Dinkel H, Van Roey K, Michael S, Kumar M, Uyar B, Altenberg B, Milchevskaya V, Schneider M, Kühn H, Behrendt A, et al: ELM 2016-data update and new functionality of the eukaryotic linear motif resource. Nucleic Acids Res. 44:D294–D300. 2016. View Article : Google Scholar

39 

Petersen TN, Brunak S, von Heijne G and Nielsen H: SignalP 4.0: Discriminating signal peptides from transmembrane regions. Nat Methods. 8:785–786. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Chou KC and Shen HB: Signal-CF: A subsite-coupled and window-fusing approach for predicting signal peptides. Biochem Biophys Res Commun. 357:633–640. 2007. View Article : Google Scholar : PubMed/NCBI

41 

Frank K and Sippl MJ: High-performance signal peptide prediction based on sequence alignment techniques. Bioinformatics. 24:2172–2176. 2008. View Article : Google Scholar : PubMed/NCBI

42 

Shen HB and Chou KC: Signal-3L: A 3-layer approach for predicting signal peptides. Biochem Biophys Res Commun. 363:297–303. 2007. View Article : Google Scholar : PubMed/NCBI

43 

Pierce BG, Wiehe K, Hwang H, Kim BH, Vreven T and Weng Z: ZDOCK server: Interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 30:1771–1773. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Pierce B and Weng Z: ZRANK: Reranking protein docking predictions with an optimized energy function. Proteins. 67:1078–1086. 2007. View Article : Google Scholar : PubMed/NCBI

45 

Beauclair G, Bridier-Nahmias A, Zagury JF, Saïb A and Zamborlini A: JASSA: A comprehensive tool for prediction of SUMOylation sites and SIMs. Bioinformatics. 31:3483–3491. 2015. View Article : Google Scholar : PubMed/NCBI

46 

Sayers EW, Agarwala R, Bolton EE, Brister JR, Canese K, Clark K, Connor R, Fiorini N, Funk K, Hefferon T, et al: Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 47:D23–D28. 2019. View Article : Google Scholar :

47 

Moult J, Fidelis K, Kryshtafovych A, Schwede T and Tramontano A: Critical assessment of methods of protein structure prediction (CASP)-Round XII. Proteins. 86(Suppl 1): S7–S15. 2018. View Article : Google Scholar

48 

Vetter IR: The structure of the G domain of the Ras superfamily. Ras superfamily small G proteins: Biology and mechanisms 1. Springer; Vienna, Vienna: pp. 25–50. 2014

49 

Chothia C and Lesk AM: The relation between the divergence of sequence and structure in proteins. EMBO J. 5:823–826. 1986. View Article : Google Scholar : PubMed/NCBI

50 

Thapliyal A, Verma R and Kumar N: Small G proteins Dexras1 and RHES and their role in pathophysiological processes. Int J Cell Biol. 2014:3085352014. View Article : Google Scholar : PubMed/NCBI

51 

Brandi V, Di Lella V, Marino M, Ascenzi P and Polticelli F: A comprehensive in silico analysis of huntingtin and its interactome. J Biomol Struct Dyn. 36:3155–3171. 2018. View Article : Google Scholar

52 

Saudou F and Humbert S: The biology of Huntingtin. Neuron. 89:910–926. 2016. View Article : Google Scholar : PubMed/NCBI

53 

Krumova P and Weishaupt JH: Sumoylation in neurodegenerative diseases. Cell Mol Life Sci. 70:2123–2138. 2013. View Article : Google Scholar

54 

Landré V, Rotblat B, Melino S, Bernassola F and Melino G: Screening for E3-ubiquitin ligase inhibitors: Challenges and opportunities. Oncotarget. 5:7988–8013. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Carbo M, Brandi V, Pascarella G, Staid DS, Colotti G, Polticelli F, Ilari A and Morea V: Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. Int J Mol Med 44: 2223-2233, 2019.
APA
Carbo, M., Brandi, V., Pascarella, G., Staid, D.S., Colotti, G., Polticelli, F. ... Morea, V. (2019). Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. International Journal of Molecular Medicine, 44, 2223-2233. https://doi.org/10.3892/ijmm.2019.4373
MLA
Carbo, M., Brandi, V., Pascarella, G., Staid, D. S., Colotti, G., Polticelli, F., Ilari, A., Morea, V."Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy". International Journal of Molecular Medicine 44.6 (2019): 2223-2233.
Chicago
Carbo, M., Brandi, V., Pascarella, G., Staid, D. S., Colotti, G., Polticelli, F., Ilari, A., Morea, V."Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy". International Journal of Molecular Medicine 44, no. 6 (2019): 2223-2233. https://doi.org/10.3892/ijmm.2019.4373
Copy and paste a formatted citation
x
Spandidos Publications style
Carbo M, Brandi V, Pascarella G, Staid DS, Colotti G, Polticelli F, Ilari A and Morea V: Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. Int J Mol Med 44: 2223-2233, 2019.
APA
Carbo, M., Brandi, V., Pascarella, G., Staid, D.S., Colotti, G., Polticelli, F. ... Morea, V. (2019). Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy. International Journal of Molecular Medicine, 44, 2223-2233. https://doi.org/10.3892/ijmm.2019.4373
MLA
Carbo, M., Brandi, V., Pascarella, G., Staid, D. S., Colotti, G., Polticelli, F., Ilari, A., Morea, V."Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy". International Journal of Molecular Medicine 44.6 (2019): 2223-2233.
Chicago
Carbo, M., Brandi, V., Pascarella, G., Staid, D. S., Colotti, G., Polticelli, F., Ilari, A., Morea, V."Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy". International Journal of Molecular Medicine 44, no. 6 (2019): 2223-2233. https://doi.org/10.3892/ijmm.2019.4373
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team